{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:46:21Z","timestamp":1791639981914,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T00:00:00Z","timestamp":1199923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s11255-007-9300-0","type":"journal-article","created":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T07:57:04Z","timestamp":1199865424000},"page":"193-201","source":"Crossref","is-referenced-by-count":49,"title":["Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial"],"prefix":"10.1007","volume":"40","author":[{"given":"Ioannis P.","family":"Tzanakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia N.","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Kagia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlassios V.","family":"Spadidakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos E.","family":"Kallivretakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Oreopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,10]]},"reference":[{"key":"9300_CR1","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthum N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208\u20132218","journal-title":"J Am Soc Nephrol"},{"key":"9300_CR2","doi-asserted-by":"crossref","unstructured":"Drueke T, Foley RN (2006) Improving outcomes in chronic kidney disease. Kidney Int Suppl 105:S1\u2013S4","DOI":"10.1038\/sj.ki.5001995"},{"key":"9300_CR3","doi-asserted-by":"crossref","unstructured":"Salusky IB (2006) A new era in phosphate binder therapy. What are the options? Kidney Int Suppl 105:S10\u2013S15","DOI":"10.1038\/sj.ki.5001997"},{"key":"9300_CR4","first-page":"880","volume":"1","author":"R O\u2019Donovan","year":"1980","unstructured":"O\u2019Donovan R, Baldwin D, Hammer M, Moniz C, Parsons V (1980) Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphatemia. Lancet 1:880\u2013882","journal-title":"Lancet"},{"key":"9300_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ki.1996.22","volume":"49","author":"JA Delmez","year":"1996","unstructured":"Delmez JA, Kelber J, Norword KY, Slatopolsky E (1996) Magnesium carbonate as a phosphate binder: a prospective, controlled, crossover study. Kidney Int 49:163\u2013167","journal-title":"Kidney Int"},{"key":"9300_CR6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1530\/acta.0.0930455","volume":"93","author":"V Parsons","year":"1980","unstructured":"Parsons V, Papapoulos SE, Weston MJ, Tomlinson S, O\u2019Riordan JL (1980) The long-term effect of lowering dialysate magnesium on circulating parathyroid hormone in patients on regular haemodialysis therapy. Acta Endocrinol (Copenh) 93:455\u2013460","journal-title":"Acta Endocrinol (Copenh)"},{"key":"9300_CR7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0272-6386(87)80021-5","volume":"10","author":"GM Shah","year":"1987","unstructured":"Shah GM, Winer RL, Cutler RE, Arief AI, Goodman WG, Lacher JW, Schoenfeld PY, Coburn JW, Horowitz AM (1987) Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis. Am J Kidney Dis 10:268\u2013275","journal-title":"Am J Kidney Dis"},{"key":"9300_CR8","first-page":"45","volume":"8","author":"H Roujouleh","year":"1987","unstructured":"Roujouleh H, Lavaud S, Toupance O, Melin GP, Chanard G (1987) Magnesium hydroxide treatment of hyperphosphatemia in chronic hemodialysis patients with an aluminum overload. Nephrology 8:45\u201350","journal-title":"Nephrology"},{"key":"9300_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000182446","volume":"30","author":"AP Guillot","year":"1982","unstructured":"Guillot AP, Hood VL, Runge CF, Gennari FJ (1982) The use of magnesium-containing in patients with end-stage renal disease on maintenance hemodialysis. Nephron 30:114\u2013117","journal-title":"Nephron"},{"key":"9300_CR10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.ndt.a091722","volume":"3","author":"P Moriniere","year":"1988","unstructured":"Moriniere P, Vinatier I, Westeel PF, Cohemsolal M, Belbrik S, Abdulmassih Z, Hocine C, Marie A, Leflon P, Roche C (1988) Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uremic patients on chronic haemodialysis: lack of deleterious effect on bone mineralization. Nephrol Dial Transplant 3:651\u2013656","journal-title":"Nephrol Dial Transplant"},{"key":"9300_CR11","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.V451205","volume":"4","author":"JT Daugirdas","year":"1993","unstructured":"Daugirdas JT (1993) Second generation logarithmic estimates of single pool variable volume Kt\/V: an analysis of error. J Am Soc Nephrol 4:1205\u20131213","journal-title":"J Am Soc Nephrol"},{"key":"9300_CR12","unstructured":"Spiegel DM, Farmer B, Chonhol M (2006) Magnesium carbonate is an effective phosphate binder. National Kidney Foundation, Spring Clinical Meeting 2006, Chicago"},{"key":"9300_CR13","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1523-1755.2004.00590.x","volume":"65","author":"WY Quinibi","year":"2004","unstructured":"Quinibi WY, Hootkins RE, McDowell LL, Meyer MS, Simon M, Garza RO, Pelham RW, Cleveland MV, Muenz LR, He DY, Nolan CR (2004) Treatment of hyperphosphatemia in hemodialysis patients: the Calcium Acetate Renagel Evaluation (CARE STUDY). Kidney Int 65:1914\u20131926","journal-title":"Kidney Int"},{"key":"9300_CR14","doi-asserted-by":"crossref","unstructured":"Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245\u2013252","DOI":"10.1046\/j.1523-1755.2002.00434.x"},{"key":"9300_CR15","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ndt\/gfh894","volume":"20","author":"HG Asmus","year":"2005","unstructured":"Asmus HG, Braun J, Krause R et al. (2005) Two year comparison of sevelamer and calcium carbonate on cardiovascular calcification and bone density. Nephrol Dial Transplant 20:1653\u20131661","journal-title":"Nephrol Dial Transplant"},{"key":"9300_CR16","unstructured":"Quinibi W, Moustafa M. Kessler P, Muenz L, Budoff M (2006) Coronary artery calcification in hemodialysis patients. Preliminary results from the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Poster presented at the 39th ASN Congress, San-Diego, CA"},{"key":"9300_CR17","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease patients. Am J Kidney Dis 42[Suppl 3]:S1\u2013S202","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"9300_CR18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev.ph.53.030191.001503","volume":"53","author":"ZS Agus","year":"1991","unstructured":"Agus ZS, Moral M (1991) Modulation of cardiac ion channels by magnesium. Ainu Rev Physiol 53:299\u2013307","journal-title":"Ainu Rev Physiol"},{"key":"9300_CR19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1159\/000064109","volume":"92","author":"AC Truttmann","year":"2002","unstructured":"Truttmann AC, Farina R, Vizier RO, Niftier JM, Pfister R, Bianchetti MG (2002) Maintenance hemodialysis and circulating ionized magnesium. Nephron 92:616\u2013621","journal-title":"Nephron"},{"key":"9300_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000045158","volume":"80","author":"H Saha","year":"1998","unstructured":"Saha H, Harmoinen A, Nisula M, Pasternack A (1998) Serum ionized versus total magnesium in patients with chronic renal disease. Nephron 80:149\u2013152","journal-title":"Nephron"},{"key":"9300_CR21","first-page":"58","volume":"18","author":"E Kelepouris","year":"1998","unstructured":"Kelepouris E, Agus ZS (1998) Hypomagnesaemia: renal magnesium handling. Semin Nephrol 18:58\u201373","journal-title":"Semin Nephrol"},{"key":"9300_CR22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/089686089701700404","volume":"17","author":"AJ Hutchison","year":"1997","unstructured":"Hutchison AJ (1997) Serum magnesium and end-stage renal disease. Perit Dial Int 17:327\u2013329","journal-title":"Perit Dial Int"},{"key":"9300_CR23","first-page":"121","volume":"3","author":"TD Mountokalakis","year":"1990","unstructured":"Mountokalakis TD (1990) Magnesium metabolism in chronic renal failure. Magnes Res 3:121\u2013127","journal-title":"Magnes Res"},{"key":"9300_CR24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0098-2997(02)00095-X","volume":"24","author":"J Maier","year":"2003","unstructured":"Maier J (2003) Low magnesium and atherosclerosis: an evidence-based link. Mol Aspects Med 24:137\u2013146","journal-title":"Mol Aspects Med"},{"key":"9300_CR25","first-page":"275","volume":"18","author":"K Ueshima","year":"2005","unstructured":"Ueshima K (2005) Magnesium and ischemic heart disease: a review of epidemiological, experimental, and clinical evidences. Magnes Res 18:275\u2013284","journal-title":"Magnes Res"},{"key":"9300_CR26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ki.1987.222","volume":"32","author":"HE Meema","year":"1987","unstructured":"Meema HE, Oreopoulos DG, Rapaport A (1987) Serum magnesium level and calcification in end-stage renal disease. Kidney Int 32:388\u2013394","journal-title":"Kidney Int"},{"key":"9300_CR27","first-page":"162","volume":"15","author":"H Izawa","year":"1974","unstructured":"Izawa H, Imura M, Kuroda M, Takeda R (1974) Effect of magnesium on secondary hyperparathyroidism in chronic hemodialysis: a case with soft tissue calcification improved by high Mg dialysate. Calcif Tissue Res 15:162","journal-title":"Calcif Tissue Res"},{"key":"9300_CR28","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/ndt\/12.9.2036","volume":"12","author":"I Tzanakis","year":"1987","unstructured":"Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V, Mayopoulou-Symvoulidou D, Kallivretakis N (1987) Mitral annular calcification in hemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 12:2036\u20132037","journal-title":"Nephrol Dial Transplant"},{"key":"9300_CR29","first-page":"102","volume":"17","author":"I Tzanakis","year":"2004","unstructured":"Tzanakis I, Virvidakis K, Tsomi A, Mantakas E, Girousis N, Karefylakis N, Papadaki A, Kallivretakis N, Mountokalakis T (2004) Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 17:102\u2013108","journal-title":"Magnes Res"},{"key":"9300_CR30","unstructured":"Tzanakis I, Tsomi A, Papadaki A, Mantakas E, Kallivretakis N (2006) The higher intracellular magnesium, the better long-term survival on hemodialysis. Poster presented at the 39th ASN Congress, San Diego, CA"},{"key":"9300_CR31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/089686080602600315","volume":"26","author":"M Wei","year":"2006","unstructured":"Wei M, Esbaei K, Bargman J, Oreopoulos D (2006) Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int 26:366\u2013373","journal-title":"Perit Dial Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-007-9300-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-007-9300-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-007-9300-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:13:36Z","timestamp":1630484016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-007-9300-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9300"],"URL":"https:\/\/doi.org\/10.1007\/s11255-007-9300-0","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,10]]}}}